JNCE logo

Jounce Therapeutics (JNCE) Selling, General & Administrative Expenses

Annual SGA

$30.97 M
+$1.99 M+6.85%

December 31, 2022

Summary

Performance

1-Year Change

+6.85%

3-Year Change

+10.92%

5-Year Change

+34.29%

15-Year Change

+34.29%

JNCE SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$30.97 M
JNCE annual SGA is currently at an all-time high

3-Year Low

$28.98 M
JNCE annual SGA is currently +6.85% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
JNCE previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
JNCE next annual earnings announcement has not yet been scheduled

OtherJNCEexpensesmetrics:

Annual Total Expenses

$134.24 M
JNCE annual total expenses is $134.24 million

Annual Operating Expenses

$134.24 M
JNCE annual total operating expenses is $134.24 million

Annual Cost Of Goods Sold

-
JNCE annual cost of goods sold value is unknown

Annual Interest Expense

-
JNCE annual interest expense value is unknown

Quarterly SGA

$8.46 M
+$805.00 K+10.52%

December 31, 2022

Summary

Performance

3-Month Change

+10.52%

1-Year Change

+17.5%

3-Year Change

+22.19%

5-Year Change

+41.34%

JNCE Quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$8.46 M
JNCE quarterly SGA is currently at an all-time high

3-Year Low

$7.20 M
JNCE quarterly SGA is currently +17.50% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2022
JNCE previous earnings announcement was published on Dec 31, 2022

Next Quarterly Earnings Report Date

N/A
JNCE next earnings announcement has not yet been scheduled

OtherJNCEexpensesmetrics:

Quarterly Total Expenses

$31.66 M
JNCE quarterly total expenses is $31.66 million

Quarterly Operating Expenses

$31.66 M
JNCE quarterly total operating expenses is $31.66 million

Quarterly Cost Of Goods Sold

-
JNCE quarterly cost of goods sold value is unknown

Quarterly Interest Expense

-
JNCE quarterly interest expense value is unknown

TTM SGA

-$1.23 B
-$50.92 M-4.32%

December 31, 2022

Summary

Performance

3-Month Change

-4235.23%

1-Year Change

-4338.67%

3-Year Change

-4500.2%

5-Year Change

-4500.2%

JNCE TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$59.47 M

3-Year Low

-$1.23 B
JNCE TTM SGA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2022
JNCE previous earnings announcement was published on Dec 31, 2022

Next Quarterly Earnings Report Date

N/A
JNCE next earnings announcement has not yet been scheduled

OtherJNCEexpensesmetrics:

Annual Total Expenses

$134.24 M
JNCE annual total expenses is $134.24 million

Annual Operating Expenses

$134.24 M
JNCE annual total operating expenses is $134.24 million

TTM Cost Of Goods Sold

-
JNCE TTM cost of goods sold value is unknown

TTM Interest Expense

-
JNCE TTM interest expense value is unknown

Selling, General & Administrative Expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

Annual SGA

$30.97 M
JNCE annual SGA is $30.97 million

Annual Operating Expenses

$134.24 M
JNCE annual total operating expenses is $134.24 million

Annual Cost Of Goods Sold

-
JNCE annual cost of goods sold value is unknown

JNCE Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+6.8%+17.5%-4338.7%
3 y3 years+10.9%+22.2%-4500.2%
5 y5 years+34.3%+41.3%-4500.2%

JNCE Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high-6.4%at high-14.9%+51.2%at low
5 y5-yearat high-9.8%at high-19.0%+152.4%at low
alltimeall timeat high-84.0%at high-68.7%+1965.8%at low

Jounce Therapeutics Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Dec 2022
$30.97 M(+6.8%)
$8.46 M(+10.5%)
$30.97 M(+4.2%)
Sep 2022
-
$7.65 M(+1.9%)
$29.71 M(+2.8%)
Jun 2022
-
$7.51 M(+2.2%)
$28.91 M(+0.7%)
Mar 2022
-
$7.35 M(+2.1%)
$28.72 M(-0.9%)
Dec 2021
$28.98 M(+0.8%)
$7.20 M(+5.0%)
$28.98 M(+1.0%)
Sep 2021
-
$6.85 M(-6.3%)
$28.68 M(-0.9%)
Jun 2021
-
$7.32 M(-3.9%)
$28.93 M(+0.3%)
Mar 2021
-
$7.62 M(+10.4%)
$28.84 M(+0.3%)
Dec 2020
$28.77 M(+3.0%)
$6.90 M(-2.9%)
$28.77 M(-0.1%)
Sep 2020
-
$7.10 M(-1.7%)
$28.79 M(+2.2%)
Jun 2020
-
$7.23 M(-4.2%)
$28.17 M(-0.3%)
Mar 2020
-
$7.54 M(+8.9%)
$28.27 M(+1.2%)
Dec 2019
$27.92 M
$6.92 M(+6.8%)
$27.92 M(+1.2%)
Sep 2019
-
$6.48 M(-11.5%)
$27.60 M(-0.1%)
Jun 2019
-
$7.32 M(+1.8%)
$27.63 M(+3.0%)
DateAnnualQuarterlyTTM
Mar 2019
-
$7.19 M(+9.0%)
$26.83 M(+1.5%)
Dec 2018
$26.44 M(+14.7%)
$6.60 M(+1.3%)
$26.44 M(+2.4%)
Sep 2018
-
$6.52 M(-0.1%)
$25.83 M(+4.6%)
Jun 2018
-
$6.52 M(-4.1%)
$24.68 M(+1.6%)
Mar 2018
-
$6.80 M(+13.7%)
$24.29 M(+5.3%)
Dec 2017
$23.06 M(+37.6%)
$5.98 M(+11.4%)
$23.06 M(+6.1%)
Sep 2017
-
$5.37 M(-12.4%)
$21.73 M(+8.9%)
Jun 2017
-
$6.13 M(+9.9%)
$19.95 M(+1.3%)
Mar 2017
-
$5.58 M(+19.9%)
$19.69 M(+17.5%)
Dec 2016
$16.76 M(+102.7%)
$4.65 M(+29.7%)
$16.76 M(+12.4%)
Sep 2016
-
$3.59 M(-38.9%)
$14.91 M(+31.7%)
Jun 2016
-
$5.87 M(+121.9%)
$11.32 M(+107.7%)
Mar 2016
-
$2.65 M(-5.6%)
$5.45 M(+94.4%)
Dec 2015
$8.27 M(+66.4%)
$2.80 M
$2.80 M
Dec 2014
$4.97 M
-
-

FAQ

  • What is Jounce Therapeutics annual SGA?
  • What is the all time high annual SGA for Jounce Therapeutics?
  • What is Jounce Therapeutics annual SGA year-on-year change?
  • What is Jounce Therapeutics quarterly SGA?
  • What is the all time high quarterly SGA for Jounce Therapeutics?
  • What is Jounce Therapeutics quarterly SGA year-on-year change?
  • What is Jounce Therapeutics TTM SGA?
  • What is the all time high TTM SGA for Jounce Therapeutics?
  • What is Jounce Therapeutics TTM SGA year-on-year change?

What is Jounce Therapeutics annual SGA?

The current annual SGA of JNCE is $30.97 M

What is the all time high annual SGA for Jounce Therapeutics?

Jounce Therapeutics all-time high annual SGA is $30.97 M

What is Jounce Therapeutics annual SGA year-on-year change?

Over the past year, JNCE annual SGA has changed by +$1.99 M (+6.85%)

What is Jounce Therapeutics quarterly SGA?

The current quarterly SGA of JNCE is $8.46 M

What is the all time high quarterly SGA for Jounce Therapeutics?

Jounce Therapeutics all-time high quarterly SGA is $8.46 M

What is Jounce Therapeutics quarterly SGA year-on-year change?

Over the past year, JNCE quarterly SGA has changed by +$1.26 M (+17.50%)

What is Jounce Therapeutics TTM SGA?

The current TTM SGA of JNCE is -$1.23 B

What is the all time high TTM SGA for Jounce Therapeutics?

Jounce Therapeutics all-time high TTM SGA is -$59.47 M

What is Jounce Therapeutics TTM SGA year-on-year change?

Over the past year, JNCE TTM SGA has changed by -$1.26 B (-4338.67%)